Published in Ann Intern Med on November 17, 2009
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol (2010) 12.64
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA (2015) 6.38
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med (2011) 4.28
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med (2011) 3.83
Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Ann Intern Med (2014) 3.78
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010. Can J Gastroenterol (2010) 3.20
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol (2013) 2.39
Possible net harms of breast cancer screening: updated modelling of Forrest report. BMJ (2011) 2.22
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med (2012) 1.99
Organizational factors and the cancer screening process. J Natl Cancer Inst Monogr (2010) 1.84
Screening mammography in older women: a review. JAMA (2014) 1.70
Cost effectiveness of the NHS breast screening programme: life table model. BMJ (2013) 1.64
Cancer risks associated with external radiation from diagnostic imaging procedures. CA Cancer J Clin (2012) 1.63
Beyond mammography: new frontiers in breast cancer screening. Am J Med (2013) 1.61
Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations. Cancer (2011) 1.59
Maximizing the impact of systematic reviews in health care decision making: a systematic scoping review of knowledge-translation resources. Milbank Q (2011) 1.54
The cost of breast cancer screening in the Medicare population. JAMA Intern Med (2013) 1.53
Update on mammography trends: comparisons of rates in 2000, 2005, and 2008. Cancer (2010) 1.52
Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med (2013) 1.51
Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res (2010) 1.47
Citations of scientific results and conflicts of interest: the case of mammography screening. Evid Based Med (2013) 1.42
Dampening enthusiasm for circulating microRNA in breast cancer. PLoS One (2013) 1.37
Tissue refractive index as marker of disease. J Biomed Opt (2011) 1.35
Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations. Implement Sci (2012) 1.34
Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines. J Gen Intern Med (2016) 1.28
Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening. Am J Hum Genet (2011) 1.26
Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer. Cancer Res (2011) 1.25
Benefits and harms of mammography screening. Breast Cancer Res (2015) 1.22
Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer (2011) 1.22
Cancer screening in patients infected with HIV. Curr HIV/AIDS Rep (2011) 1.21
Cost of breast-related care in the year following false positive screening mammograms. Med Care (2010) 1.19
Screening outcomes following implementation of digital breast tomosynthesis in a general-population screening program. J Natl Cancer Inst (2014) 1.18
Designing a patient-centered personal health record to promote preventive care. BMC Med Inform Decis Mak (2011) 1.17
Decreasing disparities in breast cancer screening in refugee women using culturally tailored patient navigation. J Gen Intern Med (2013) 1.17
Targeting of mammography screening according to life expectancy in women aged 75 and older. J Am Geriatr Soc (2013) 1.17
Screening mammography beliefs and recommendations: a web-based survey of primary care physicians. BMC Health Serv Res (2012) 1.15
Benefits of screening mammography. JAMA (2010) 1.15
Mammography use among women ages 40-49 after the 2009 U.S. Preventive Services Task Force recommendation. J Gen Intern Med (2013) 1.12
Using visual aids to improve communication of risks about health: a review. ScientificWorldJournal (2012) 1.12
Women's responses to changes in U.S. Preventive Task Force's mammography screening guidelines: results of focus groups with ethnically diverse women. BMC Public Health (2013) 1.10
Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening. J Natl Cancer Inst (2015) 1.10
Breast cancer screening trends in the United States and ethnicity. Cancer Epidemiol Biomarkers Prev (2011) 1.09
The breast screening programme and misinforming the public. J R Soc Med (2011) 1.09
Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts. AJR Am J Roentgenol (2015) 1.08
The Effect of Budgetary Restrictions on Breast Cancer Diagnostic Decisions. Manuf Serv Oper Manag (2012) 1.08
Hollow silica and silica-boron nano/microparticles for contrast-enhanced ultrasound to detect small tumors. Biomaterials (2012) 1.06
What is lacking in current decision aids on cancer screening? CA Cancer J Clin (2013) 1.06
Randomized trial of personal genomics for preventive cardiology: design and challenges. Circ Cardiovasc Genet (2012) 1.06
Integrating age and comorbidity to assess screening mammography utilization. Am J Prev Med (2012) 1.05
From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program. Cancer (2014) 1.02
Breast cancer screening: the questions answered. Nat Rev Clin Oncol (2012) 1.02
Point: Mammography screening-sticking to the science. Curr Oncol (2015) 1.01
Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial). Breast Cancer Res Treat (2011) 1.00
Mammogram image quality as a potential contributor to disparities in breast cancer stage at diagnosis: an observational study. BMC Cancer (2013) 1.00
Quality-of-life issues in patients with ductal carcinoma in situ. J Natl Cancer Inst Monogr (2010) 1.00
Public health national approach to reducing breast and cervical cancer disparities. Cancer (2014) 0.99
Racial differences in breast cancer stage at diagnosis in the mammography era. Am J Public Health (2012) 0.99
Language barriers, location of care, and delays in follow-up of abnormal mammograms. Med Care (2012) 0.99
Breast cancer screening of underserved women in the USA: results from the National Breast and Cervical Cancer Early Detection Program, 1998-2012. Cancer Causes Control (2015) 0.98
Pathogenesis, prevention, diagnosis and treatment of breast cancer. World J Clin Oncol (2014) 0.98
Beyond the mammography debate: a moderate perspective. Curr Oncol (2015) 0.97
Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention. Breast Cancer Res Treat (2013) 0.96
Potential overuse of screening mammography and its association with access to primary care. Med Care (2014) 0.96
Future directions for the early detection of recurrent breast cancer. J Cancer (2014) 0.95
In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters. Radiology (2012) 0.94
Impact of provider-patient communication on cancer screening adherence: A systematic review. Prev Med (2016) 0.94
Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis. Cancer (2011) 0.94
Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data. Ann Intern Med (2016) 0.94
Effects of age on the detection and management of breast cancer. Cancers (Basel) (2015) 0.94
Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study. Am J Gastroenterol (2012) 0.93
Sodium MRI: methods and applications. Prog Nucl Magn Reson Spectrosc (2014) 0.93
Disparities in mammography rate among immigrant and native-born women in the U.S.: progress and challenges. J Immigr Minor Health (2014) 0.93
Prediction of near-term breast cancer risk based on bilateral mammographic feature asymmetry. Acad Radiol (2013) 0.92
Intensified surveillance for early detection of breast cancer in high-risk patients. Breast Care (Basel) (2015) 0.92
Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast. Med Phys (2010) 0.92
Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer. Br J Cancer (2010) 0.91
Strategies for increasing mammography screening in primary care in Chile: results of a randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2010) 0.91
Knowledge of risk factors, beliefs and practices of female healthcare professionals towards breast cancer, Morocco. Pan Afr Med J (2011) 0.91
Actualizing Personalized Healthcare for Women through Connected Data Systems: Breast Cancer Screening and Diagnosis. Glob Adv Health Med (2013) 0.90
Genetic variants improve breast cancer risk prediction on mammograms. AMIA Annu Symp Proc (2013) 0.90
Patients' expectations of screening and preventive treatments. Ann Fam Med (2012) 0.90
Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer (2013) 0.89
A cluster-randomized trial of a primary care informatics-based system for breast cancer screening. J Gen Intern Med (2010) 0.89
The background review for the USPSTF recommendation on screening for breast cancer. Ann Intern Med (2010) 0.89
Breast MRI use uncommon among U.S. women. Cancer Epidemiol Biomarkers Prev (2012) 0.89
Changes in the availability of screening mammography, 2000-2010. Cancer (2013) 0.89
Mammographic features associated with interval breast cancers in screening programs. Breast Cancer Res (2014) 0.89
A systematic review of special events to promote breast, cervical and colorectal cancer screening in the United States. BMC Public Health (2014) 0.88
Nuclear imaging of the breast: translating achievements in instrumentation into clinical use. Med Phys (2013) 0.88
Patient understanding of the revised USPSTF screening mammogram guidelines: need for development of patient decision aids. BMC Womens Health (2012) 0.88
Breast and cervical cancers diagnosed and stage at diagnosis among women served through the National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 0.88
Breast cancer screening among adult women in China, 2010. Prev Chronic Dis (2013) 0.88
Racial and ethnic differences in use of mammography between Medicare Advantage and traditional Medicare. J Natl Cancer Inst (2013) 0.88
Mammography Decision Aid Reduces Decisional Conflict for Women in Their Forties Considering Screening. J Womens Health (Larchmt) (2015) 0.87
Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med (2005) 16.70
Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet (2002) 13.16
Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 12.65
The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med (2007) 12.23
Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med (1998) 12.20
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med (2001) 7.94
Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol (1997) 7.62
Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet (2006) 6.78
Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer? CMAJ (2001) 6.08
Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ (2006) 5.82
Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst (2002) 5.57
The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med (2002) 5.17
Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst (2007) 5.08
Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading. BMJ (1999) 4.94
Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ (2004) 4.94
Screening for breast cancer: recommendations and rationale. Ann Intern Med (2002) 4.90
Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med (2007) 4.68
Comparison of screening mammography in the United States and the United kingdom. JAMA (2003) 4.53
Performance benchmarks for screening mammography. Radiology (2006) 4.41
Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med (2007) 4.26
Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst (2000) 4.13
Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol (2008) 3.49
Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer (1995) 3.32
Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev (2003) 3.22
The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am (2000) 3.18
Association between mammography timing and measures of screening performance in the United States. Radiology (2005) 2.85
Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res (2005) 2.81
Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res (2005) 2.67
The Gothenburg Breast Screening Trial. Cancer (2003) 2.59
The psychological impact of mammographic screening. A systematic review. Psychooncology (2005) 2.33
Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer (2003) 2.26
Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J (2006) 2.24
Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Res (2006) 1.79
Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer (2003) 1.70
The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program. Cancer (2004) 1.62
Overdiagnosis and breast cancer screening. Breast Cancer Res (2005) 1.59
Estimating the accuracy of screening mammography: a meta-analysis. Am J Prev Med (1998) 1.55
The role of breast self-examination in early breast cancer detection (results of the 5-years USSR/WHO randomized study in Leningrad). Eur J Epidemiol (1992) 1.55
Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer (2006) 1.54
Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. J Natl Cancer Inst (1986) 1.50
Breast self-examination and death from breast cancer: a meta-analysis. Br J Cancer (2003) 1.47
Routine screening mammography in women older than 74 years: a review of the available data. Maturitas (2007) 1.32
Breast screening in the emerging world: high prevalence of breast cancer in Cairo. Breast (2005) 1.27
[Interim results of a prospective randomized study of self-examination for early detection of breast cancer (Russia/St.Petersburg/WHO)]. Vopr Onkol (1999) 1.21
[Results of a prospective randomized investigation [Russia (St.Petersburg)/WHO] to evaluate the significance of self-examination for the early detection of breast cancer]. Vopr Onkol (2003) 1.18
Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data. Breast Cancer Res (2005) 1.18
Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry. Int J Cancer (2007) 1.17
Does mammographic screening and a negative result affect attitudes towards future breast screening? J Med Screen (2001) 1.17
Breast self-examination: self-reported frequency, quality, and associated outcomes. J Cancer Educ (2006) 1.08
The additional diagnostic value of ultrasonography in the diagnosis of breast cancer. Arch Intern Med (2003) 1.06
Trends in mammography and clinical breast examination: a population-based study. J Surg Res (2007) 1.05
False positive rate of screening mammography. N Engl J Med (1998) 0.97
Targeted therapies in breast cancer. Breast J (2005) 0.96
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 16.82
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 15.83
Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2011) 9.50
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 8.14
Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 6.78
Screening for colorectal cancer: recommendation and rationale. Ann Intern Med (2002) 6.56
Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 6.26
Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care. Ann Intern Med (2012) 6.06
Screening for prostate cancer: recommendation and rationale. Ann Intern Med (2002) 6.04
Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 6.01
Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med (2011) 5.46
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med (2005) 5.24
Screening for breast cancer: recommendations and rationale. Ann Intern Med (2002) 4.90
The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med (2015) 4.75
The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 4.74
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med (2005) 4.66
Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2003) 4.55
Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. Ann Intern Med (2004) 4.52
Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA (2006) 4.39
Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2015) 4.11
Screening for obesity in adults: recommendations and rationale. Ann Intern Med (2003) 4.10
Screening for depression: recommendations and rationale. Ann Intern Med (2002) 3.88
Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 3.73
Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 3.65
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 3.64
Screening women for intimate partner violence: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med (2012) 3.55
Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med (2005) 3.35
Routine iron supplementation and screening for iron deficiency anemia in pregnancy: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2015) 3.31
Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 3.27
Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 3.26
Can administrative data be used to compare postoperative complication rates across hospitals? Med Care (2002) 3.17
Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 3.11
Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit. Ann Intern Med (2007) 3.03
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2016) 3.02
Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med (2002) 2.98
Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med (2002) 2.95
Behavioral counseling in primary care to promote physical activity: recommendation and rationale. Ann Intern Med (2002) 2.94
Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 2.93
Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med (2009) 2.86
Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer. Ann Intern Med (2009) 2.79
Screening for hypertension in children and adolescents to prevent cardiovascular disease. Pediatrics (2013) 2.77
Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2015) 2.73
Pressure ulcer risk assessment and prevention: a systematic comparative effectiveness review. Ann Intern Med (2013) 2.71
Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.57
Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.53
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 2.53
Screening for suicide risk in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.49
Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2007) 2.32
Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.20
Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2014) 2.16
Prevention of falls in community-dwelling older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 2.15
Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2009) 2.09
Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2015) 2.08
Breast cancer screening: from science to recommendation. Radiology (2010) 2.06
Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2009) 2.04
Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 2.03
Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 1.97
Aspirin for the primary prevention of cardiovascular events: recommendations and rationale. Am Fam Physician (2002) 1.95
Screening for High Blood Pressure in Adults: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2015) 1.94
Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.87
Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2008) 1.85
Screening for coronary heart disease: recommendation statement. Ann Intern Med (2004) 1.84
Chemoprevention of breast cancer: recommendations and rationale. Ann Intern Med (2002) 1.84
Screening for hepatitis B virus infection in nonpregnant adolescents and adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.83
Screening for type 2 diabetes mellitus in adults: recommendations and rationale. Ann Intern Med (2003) 1.81
Screening for osteoporosis: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2010) 1.76
Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2007) 1.75
Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med (2016) 1.74
The effectiveness of primary care-based interventions to promote breastfeeding: systematic evidence review and meta-analysis for the US Preventive Services Task Force. Ann Fam Med (2004) 1.72
Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2007) 1.71
Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.70
Screening for intimate partner violence and abuse of elderly and vulnerable adults: U.S. preventive services task force recommendation statement. Ann Intern Med (2013) 1.68
Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med (2016) 1.68
Universal newborn hearing screening: systematic review to update the 2001 US Preventive Services Task Force Recommendation. Pediatrics (2008) 1.66
Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 1.63
Behavioral counseling to prevent skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 1.60
Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2012) 1.58
Screening for testicular cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2011) 1.56
Screening for hepatitis C virus infection in adults: recommendation statement. Ann Intern Med (2004) 1.56
Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 1.55
Surgical menopause and nonvertebral fracture risk among older US women. Menopause (2012) 1.52
Screening for family and intimate partner violence: recommendation statement. Ann Fam Med (2004) 1.47
Primary care behavioral interventions to reduce illicit drug and nonmedical pharmaceutical use in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.47
Screening for hemochromatosis: recommendation statement. Ann Intern Med (2006) 1.44
Screening asymptomatic adults with resting or exercise electrocardiography: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2011) 1.41
Screening for suicide risk: recommendation and rationale. Ann Intern Med (2004) 1.40
Current processes of the U.S. Preventive Services Task Force: refining evidence-based recommendation development. Ann Intern Med (2007) 1.40
Lung cancer screening: recommendation statement. Ann Intern Med (2004) 1.38
Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 1.37
Screening for thyroid disease: recommendation statement. Ann Intern Med (2004) 1.36
The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2. Cancer Res (2005) 1.34
Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med (2005) 1.31
Screening for gonorrhea: recommendation statement. Ann Fam Med (2005) 1.31
Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 1.30
Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial. Breast Cancer Res Treat (2011) 1.29
Screening for chlamydial infection: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 1.29
Screening for carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2007) 1.28